Table 1.
The Baseline Characteristics of Ovarian Cancer Patients
| All OC Patients | Patients with OC-Associated CI | Percentagea | P-value (Chi-Square) | |
|---|---|---|---|---|
| Cases | 2632 | 30 | 1.1% | - |
| Age (years) | 50 (0–89) | 60 (37–83) | – | – |
| FIGO stage | ||||
| I | 409 (15.5%) | 5 (16.7%) | 1.2% | >0.999 |
| II | 176 (6.7%) | 4 (13.3%) | 2.3% | 0.282 |
| III | 1118 (42.5%) | 17 (56.7%) | 1.5% | 0.118 |
| IV | 201 (7.6%) | 4 (13.3%) | 3.6% | 0.413 |
| Unknown | 728 (27.7%) | 0 (0.0%) | 0.0% | – |
| Histologic classification | ||||
| Serous | 1752 (66.6%) | 19 (63.3%) | 1.2% | 0.709 |
| Mucinous | 140 (5.3%) | 1 (3.3%) | 0.7% | 0.942 |
| Endometrioid | 227 (8.6%) | 4 (13.3%) | 1.7% | 0.559 |
| Clear cell | 312 (11.9%) | 3 (10.0%) | 1.0% | 0.977 |
| Others or unknown | 201 (7.6%) | 3 (10.0%) | 1.5% | 0.890 |
Notes: Data are shown as median (range) or number (percentage). aPatients with OC-associated CI in all OC patients.
Abbreviations: OC, ovarian cancer; CI, cerebral infarction; FIGO, International Federation of Gynecology and Obstetrics.